Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE:DBD)
Vietnam · Delayed Price · Currency is VND 45,150
-400 (-0.88%)
At close: Nov 3, 2026
HOSE:DBD Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,266,190 | 4,611,076 | 5,388,697 | 4,056,516 | 2,952,575 | 2,987,797 | |
Market Cap Growth | -14.16% | -14.43% | 32.84% | 37.39% | -1.18% | 16.65% |
Enterprise Value | 4,112,790 | 4,257,305 | 5,044,563 | 3,901,580 | 2,782,729 | 2,976,248 |
Last Close Price | 45150.00 | 46848.00 | 53321.14 | 40138.97 | 27749.27 | 28082.03 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.59 | 18.37 | 22.77 | 17.53 | 14.10 | 18.37 |
Forward PE | - | 18.50 | 19.36 | 13.51 | 12.33 | 12.11 |
PS Ratio | 2.26 | 2.47 | 3.12 | 2.46 | 1.90 | 1.92 |
PB Ratio | 2.35 | 2.66 | 3.24 | 2.83 | 2.18 | 2.62 |
P/TBV Ratio | 2.46 | 2.79 | 3.36 | 2.95 | 2.28 | 2.77 |
P/FCF Ratio | - | 22.32 | 46.46 | 27.29 | 35.93 | 47.48 |
P/OCF Ratio | 20.84 | 7.50 | 20.36 | 14.37 | 17.89 | 25.41 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.18 | 2.28 | 2.92 | 2.36 | 1.79 | 1.91 |
EV/EBITDA Ratio | 10.20 | 11.33 | 14.26 | 11.38 | 8.83 | 11.63 |
EV/EBIT Ratio | 11.36 | 13.05 | 16.51 | 13.14 | 10.18 | 13.71 |
EV/FCF Ratio | - | 20.61 | 43.49 | 26.25 | 33.86 | 47.29 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.22 | 0.10 | 0.04 | 0.06 | 0.06 | 0.09 |
Debt / EBITDA Ratio | 1.08 | 0.47 | 0.18 | 0.23 | 0.24 | 0.38 |
Debt / FCF Ratio | - | 0.85 | 0.55 | 0.53 | 0.93 | 1.54 |
Net Debt / Equity Ratio | -0.08 | -0.25 | -0.23 | -0.16 | -0.15 | -0.10 |
Net Debt / EBITDA Ratio | -0.42 | -1.16 | -1.06 | -0.67 | -0.64 | -0.44 |
Net Debt / FCF Ratio | 2.17 | -2.11 | -3.23 | -1.55 | -2.44 | -1.77 |
Asset Turnover | 0.72 | 0.77 | 0.81 | 0.85 | 0.90 | 1.04 |
Inventory Turnover | 2.37 | 2.25 | 1.80 | 1.82 | 2.23 | 3.97 |
Quick Ratio | 1.57 | 1.79 | 1.92 | 1.79 | 1.88 | 2.25 |
Current Ratio | 2.51 | 2.52 | 3.21 | 3.02 | 3.08 | 3.30 |
Return on Equity (ROE) | 17.84% | 17.19% | 17.79% | 19.30% | 19.52% | 17.77% |
Return on Assets (ROA) | 7.72% | 8.39% | 8.98% | 9.56% | 9.89% | 9.06% |
Return on Invested Capital (ROIC) | 17.28% | 21.29% | 20.78% | 21.18% | 20.43% | 18.62% |
Return on Capital Employed (ROCE) | 14.80% | 16.20% | 16.90% | 18.90% | 18.30% | 17.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.42% | 6.33% | 5.11% | 6.63% | 8.25% | 6.33% |
FCF Yield | -1.66% | 4.48% | 2.15% | 3.67% | 2.78% | 2.11% |
Dividend Yield | 4.43% | - | 3.47% | - | 5.07% | - |
Payout Ratio | 56.95% | 63.58% | 0.00% | 55.64% | - | 39.95% |
Buyback Yield / Dilution | - | -0.34% | - | 0.00% | - | 0.07% |
Total Shareholder Return | 4.43% | -0.34% | 3.47% | 0.00% | 5.07% | 0.07% |